Summary:
Is COPD taking the wind out of your sails? This study is for people with moderate-severe COPD using a new drug called Tudorza Pressair (or Aclidinium Bromide) which is already available by prescription.
Qualified Participants Must:
• Have one COPD exacerbation in the last year
•
Be 40 yearsof age or older
•
Be a past or present smoker
Qualified Participants May Receive:
$85 per visit, study medication at no cost, pulmonary function test, chest x-ray, labwork, ECG and evaluations by experienced doctors and nurses.